| Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line N Barboule, P Chadebech, V Baldin, S Vidal, A Valette Oncogene 15 (23), 2867-2875, 1997 | 129 | 1997 |
| Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death P Chadebech, A Habibi, R Nzouakou, D Bachir, N Meunier‐Costes, ... Transfusion 49 (9), 1785-1792, 2009 | 126 | 2009 |
| Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease D Narbey, A Habibi, P Chadebech, A Mekontso‐Dessap, M Khellaf, ... American journal of hematology 92 (12), 1340-1348, 2017 | 110 | 2017 |
| Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease F Noizat-Pirenne, D Bachir, P Chadebech, M Michel, A Plonquet, ... Haematologica 92 (12), e132-e135, 2007 | 91 | 2007 |
| Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition N Barboule, C Lafon, P Chadebech, S Vidal, A Valette FEBS letters 444 (1), 32-37, 1999 | 85 | 1999 |
| Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage P Chadebech, L Brichese, V Baldin, S Vidal, A Valette Biochemical and biophysical research communications 262 (3), 823-827, 1999 | 74 | 1999 |
| Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy LT Roumenina, P Chadebech, G Bodivit, P Vieira‐Martins, A Grunenwald, ... American journal of hematology 95 (5), 456-464, 2020 | 64 | 2020 |
| The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease F Noizat‐Pirenne, A Habibi, A Mekontso‐Dessap, K Razazi, ... Vox sanguinis 108 (3), 262-267, 2015 | 59 | 2015 |
| Use of human reconstructed epidermis to analyze the regulation of β-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS P Chadebech, D Goidin, C Jacquet, J Viac, D Schmitt, MJ Staquet Cell biology and toxicology 19, 313-324, 2003 | 57 | 2003 |
| Up‐regulation of cdc2 protein during paclitaxel‐induced apoptosis P Chadebech, I Truchet, L Brichese, A Valette International journal of cancer 87 (6), 779-786, 2000 | 51 | 2000 |
| IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI P Chadebech, M Michel, D Janvier, K Yamada, C Copie-Bergman, ... Blood, The Journal of the American Society of Hematology 116 (20), 4141-4147, 2010 | 46 | 2010 |
| Red blood cell Thomsen‐Friedenreich antigen expression and galectin‐3 plasma concentrations in Streptococcus pneumoniae–associated hemolytic uremic … N Burin des Roziers, P Chadebech, G Bodivit, E Guinchard, A Bruneel, ... Transfusion 55 (6pt2), 1563-1571, 2015 | 28 | 2015 |
| Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease N Hebert, MG Rakotoson, G Bodivit, E Audureau, L Bencheikh, L Kiger, ... American Journal of Hematology 95 (11), 1235-1245, 2020 | 27 | 2020 |
| Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply N Meunier, M Rodet, P Bonin, P Chadebech, B Chami, K Lee, A Habibi, ... Transfusion Clinique et Biologique: Journal de la Societe Francaise de …, 2008 | 23 | 2008 |
| Anti‐HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients C Ibanez, A Habibi, A Mekontso‐Dessap, P Chadebech, B Chami, ... Transfusion 56 (7), 1828-1833, 2016 | 20 | 2016 |
| Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T‐polyagglutination J Moh‐Klaren, G Bodivit, M Jugie, P Chadebech, L Chevret, M Mokhtari, ... Transfusion 57 (11), 2571-2577, 2017 | 18 | 2017 |
| Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease P Chadebech, MA de Ménorval, G Bodivit, A Mekontso‐Dessap, ... Transfusion 56 (7), 1730-1738, 2016 | 15 | 2016 |
| Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic … S Chevret, S Verlhac, E Ducros-Miralles, JH Dalle, RP de Latour, ... Contemporary Clinical Trials 62, 91-104, 2017 | 12 | 2017 |
| Anti‐T haemolysins: the effects of sialic acid removal and 2‐aminoethylisothiouronium bromide treatment of erythrocytes on immune lysis NB Des Roziers, G Bodivit, P Chadebech, R Nzouakou, P Bierling, ... Vox sanguinis 100 (4), 401-408, 2011 | 12 | 2011 |
| Étude d’une cohorte de 206 patients drépanocytaires adultes transfusés: immunisation, risque transfusionnel et ressources en concentrés globulaires N Meunier, M Rodet, P Bonin, P Chadebech, B Chami, K Lee, A Habibi, ... Transfusion clinique et biologique 15 (6), 377-382, 2008 | 11 | 2008 |
keyvan RazaziRéanimation médicale Hôpital Henri Mondor在 aphp.fr 的电子邮件经过验证
